Sign In
Buy BIIB
$196.45
+0.490 (+0.250%)
At Close: Jun 04, 2026
Ionis (IONS) Q1 Earnings & Sales Beat Estimates, Stock Rises
03:45pm, Thursday, 05'th May 2022 Zacks Investment Research
Ionis (IONS) incurs a narrower-than-expected loss in Q1. Its sales also come ahead of estimates. Stock moves up in response to the results.
Analyst Upgrades and Research Reports for Oracle, Union Pacific, Ford & Others
03:32pm, Thursday, 05'th May 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Union Pacific Corporation (UNP), and Ford Motor Company (F).
Beset by challenges with its Alzheimer's drug, Biogen pivots
11:38am, Thursday, 05'th May 2022 MarketWatch
The company plans to let go of its CEO and scrap commercial plans for its controversial Alzheimer’s disease drug.
Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis
11:30am, Thursday, 05'th May 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass. and PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and MedRhythms have entered into a license agreement to develop and commercialize MR-004, an investi
1 Reason to Buy Biogen Now, and 1 Reason to Wait
10:00am, Thursday, 05'th May 2022 The Motley Fool
The company just announced some big changes.
Biotech Stock Roundup: BIIB & GILD's Earnings Update, VRTX Down on Regulatory News
05:39pm, Wednesday, 04'th May 2022 Zacks Investment Research
Earnings and regulatory updates from Bristol Myers (BMY), among others, and Vertex (VRTX) are a few key highlights from the biotech sector during the past week.
10 Biggest Price Target Changes For Wednesday
11:44am, Wednesday, 04'th May 2022 Benzinga
RBC Capital boosted Atkore Inc. (NYSE: ATKR) price target from $123 to $170. Atkore shares rose 0.2% to $109.00 in pre-market trading.
UBS raised the price target for Airbnb, Inc. (NASDAQ: ABNB) f
U.S. stock benchmarks end higher after choppy trade on eve of expected half-point Fed interest rate hike
08:27pm, Tuesday, 03'rd May 2022 MarketWatch
U.S. stock indexes end higher Tuesday after choppy trade on the eve of what's expected to be the most aggressive Federal Reserve tightening in two decades.
Biogen CEO's surprising step-down
07:08pm, Tuesday, 03'rd May 2022
CNBC's Meg Tirrell on Biogen CEO Michel Vounatsos leaving the company. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Steve Grasso.
Biogen (BIIB) Q1 2022 Earnings Call Transcript
05:01pm, Tuesday, 03'rd May 2022 The Motley Fool
BIIB earnings call for the period ending March 31, 2022.
Called to Account: Drug companies are making an accounting change after the SEC cracked down on Biogen
03:04pm, Tuesday, 03'rd May 2022
Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in w
Biogen (BIIB) Q1 Earnings Miss, Aduhelm Setback Leads to Rejig
02:55pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Biogen (BIIB) misses first-quarter estimates for earnings but beats the same for sales. Following no medicare beneficiary access to Aduhelm, Biogen initiates a cost-savings program.
Stocks may keep sliding until institutions join retail investors in capitulation, this firm says
01:50pm, Tuesday, 03'rd May 2022 MarketWatch
As the Fed meeting looms, strategists are mapping out where they think the S&P 500 is headed next. Sub-4,000 to be sure.
BIIB Stock Treks Higher Amid News That Biogen CEO Michel Vounatsos Is Stepping Down
01:11pm, Tuesday, 03'rd May 2022
Drug-making giant Biogen is in the green today after announcing CEO Michel Vounatsos is stepping down from the role. The post BIIB Stock Treks Higher Amid News That Biogen CEO Michel Vounatsos Is Step
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
01:01pm, Tuesday, 03'rd May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Acadia Announces FDA AdComm For Pimavanserin In Alzheimer's-Related Psychosis
The FDA's Psychopharmaco
